233 related articles for article (PubMed ID: 2240470)
1. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
Yeager AM; Rowley SD; Kaizer H; Santos GW
Am J Pediatr Hematol Oncol; 1990; 12(3):245-56. PubMed ID: 2240470
[TBL] [Abstract][Full Text] [Related]
2. Induction of cutaneous graft-versus-host disease by administration of cyclosporine to patients undergoing autologous bone marrow transplantation for acute myeloid leukemia.
Yeager AM; Vogelsang GB; Jones RJ; Farmer ER; Altomonte V; Hess AD; Santos GW
Blood; 1992 Jun; 79(11):3031-5. PubMed ID: 1586747
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
Lenarsky C; Weinberg K; Petersen J; Nolta J; Brooks J; Annett G; Kohn D; Parkman R
Bone Marrow Transplant; 1990 Dec; 6(6):425-9. PubMed ID: 2097012
[TBL] [Abstract][Full Text] [Related]
4. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
[TBL] [Abstract][Full Text] [Related]
5. Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.
Petersen FB; Lynch MH; Clift RA; Appelbaum FR; Sanders JE; Bensinger WI; Benyunes MC; Doney K; Fefer A; Martin P
J Clin Oncol; 1993 Jul; 11(7):1353-60. PubMed ID: 8315433
[TBL] [Abstract][Full Text] [Related]
6. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
Yeager AM; Kaizer H; Santos GW; Saral R; Colvin OM; Stuart RK; Braine HG; Burke PJ; Ambinder RF; Burns WH
N Engl J Med; 1986 Jul; 315(3):141-7. PubMed ID: 3523241
[TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Meloni G; Korbling M; Carella A; Herve P; Burnett A; Rizzoli V; Alessandrino EP; Bjorkstrand B
Leukemia; 1991 Oct; 5(10):896-904. PubMed ID: 1835746
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome for high-risk acute myeloid leukemia patients using autologous bone marrow transplantation and monoclonal antibody-purged bone marrow.
Selvaggi KJ; Wilson JW; Mills LE; Cornwell GG; Hurd D; Dodge W; Gingrich R; Martin SE; McMillan R; Miller W
Blood; 1994 Mar; 83(6):1698-705. PubMed ID: 8123862
[TBL] [Abstract][Full Text] [Related]
9. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
Miller CB; Rowlings PA; Zhang MJ; Jones RJ; Piantadosi S; Keating A; Armitage JO; Calderwood S; Harris RE; Klein JP; Lazarus HM; Linker CA; Sobocinski KA; Weisdorf D; Horowitz MM
Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
[TBL] [Abstract][Full Text] [Related]
10. Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation.
Shaw PJ; Bergin ME; Burgess MA; Dalla Pozza L; Kellie SJ; Rowell G; Stevens MM; Webster BH; Bradstock KF
J Clin Oncol; 1994 Oct; 12(10):2138-45. PubMed ID: 7931485
[TBL] [Abstract][Full Text] [Related]
11. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience.
Laporte JP; Douay L; Lopez M; Labopin M; Jouet JP; Lesage S; Stachowiak J; Fouillard L; Isnard F; Noel-Walter MP
Blood; 1994 Dec; 84(11):3810-8. PubMed ID: 7949137
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
Smith BD; Jones RJ; Lee SM; Piantadosi S; Vala MS; Fuller D; Gore SD; Noga SJ; O'Donnell PV; Braine H; Vogelsang GB; Fuchs EJ; Flinn IW; Brodsky RA; Ambinder RF; Miller CB
Br J Haematol; 2002 Jun; 117(4):907-13. PubMed ID: 12060130
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow transplantation in acute leukemia.
Gorin NC
J Natl Cancer Inst; 1986 Jun; 76(6):1281-7. PubMed ID: 2940400
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience.
Chopra R; Goldstone AH; McMillan AK; Powles R; Smith AG; Prentice HG; Reid C; Marcus R; Bell A; Milligan D
J Clin Oncol; 1991 Oct; 9(10):1840-7. PubMed ID: 1919634
[TBL] [Abstract][Full Text] [Related]
15. The role of thiotepa in autologous bone marrow transplantation for acute leukemia.
Nagler A; Finlander R; Or R; Naparstek E; Varadi G; Slavin S
Leuk Res; 1998 Nov; 22(11):991-5. PubMed ID: 9783800
[TBL] [Abstract][Full Text] [Related]
16. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.
Chantry AD; Snowden JA; Craddock C; Peggs K; Roddie C; Craig JI; Orchard K; Towlson KE; Pearce RM; Marks DI;
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1310-7. PubMed ID: 17162213
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging.
Uckun FM; Kersey JH; Vallera DA; Ledbetter JA; Weisdorf D; Myers DE; Haake R; Ramsay NK
Blood; 1990 Nov; 76(9):1723-33. PubMed ID: 2224122
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia.
Gonzales-Chambers R; Przepiorka D; Shadduck RK; Borochovitz D; Bloom EJ; Colvin OM; Mangan KF; Rosenfeld CS
Med Pediatr Oncol; 1991; 19(3):160-4. PubMed ID: 2023563
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
